SHAREHOLDER ALERT: WeissLaw LLP Investigates Zogenix, Inc.

Provided By PR Newswire

Last update: Jan 20, 2022

NEW YORK, Jan. 19, 2022 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Zogenix, Inc. ("Zogenix" or the "Company") (NASDAQ: ZGNX), in connection with the proposed acquisition of the Company by UCB S.A. ("UCB") (Euronext: UCB) via a tender offer. Under the terms of the acquisition agreement, the Company's shareholders will receive $26.00 in cash, plus a contingent value right for a potential cash payment of $2.00, for each share of Zogenix common stock that they hold. The transaction is valued at approximately $1.9 billion.